You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020241029
Dec 20206207
Jan 2021141015
Feb 2021107026
Mar 2021196023
Apr 2021192025
May 202177030
Jun 20210046
Jul 20210038
Aug 20210041
Sep 202100140
Oct 2021675067
Nov 2021512079
Dec 2021606064
Jan 2022352032
Feb 2022218051
Mar 2022214078
Apr 2022324039
May 2022446074
Jun 2022238044
Jul 2022396044
Aug 2022354050
Sep 2022244051
Oct 2022340036
Nov 2022290051
Dec 2022304040
Jan 2023308038
Feb 2023286052
Mar 2023344034
Apr 2023408047
May 2023332039
Jun 2023258024
Jul 2023820065
Aug 2023296053
Sep 2023314043
Oct 2023186021
Nov 2023228019
Dec 2023144011
Jan 202411805
Feb 2024118015
Mar 2024226023
Apr 2024182017
May 2024176021
Jun 2024352021
Jul 2024146025
Aug 2024123014
Sep 2024172013
Oct 2024176032
Nov 2024150015
Dec 2024110013
Jan 2025122046
Feb 20252807
Mar 20250018
Apr 20250012
May 20250023
Jun 20251017
Total1265302003